Evogene (XTAE:EVGN) Marketable Securities : ₪38.43 Mil (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Evogene Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Evogene's Marketable Securities for the quarter that ended in Dec. 2023 was ₪38.43 Mil.

Evogene's annual Marketable Securities declined from Dec. 2021 (₪80.44 Mil) to Dec. 2022 (₪23.81 Mil) but then increased from Dec. 2022 (₪23.81 Mil) to Dec. 2023 (₪38.43 Mil).

Evogene Marketable Securities Historical Data

The historical data trend for Evogene's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evogene Marketable Securities Chart

Evogene Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

45.29

7.47

80.44

23.81

38.43

Evogene Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Marketable Securities	Get a 7-Day Free Trial															23.81	21.64	50.94	36.95	38.43

Evogene Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Evogene (XTAE:EVGN) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Evogene Marketable Securities Related Terms

Thank you for viewing the detailed overview of Evogene's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Evogene (XTAE:EVGN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Evogene Ltd (XTAE:EVGN) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

EVGN:USA

Address

13 Gad Feinstein Street, Park Rehovot, P.O. Box 4173, Ness Ziona, Rehovot, ISR, 7414002

Website

https://www.evogene.com

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment.